refer
antiserum
sar
urgent
need
develop
sar
vaccin
serolog
test
sar
research
convalesc
serum
collect
clinic
confirm
patient
elisa
westernblot
neutral
assay
detect
specif
antibodi
sar
coronaviru
antiserum
prepar
inhous
refer
antiserum
freezedri
seal
ampoul
potenc
refer
antiserum
defin
u
extens
calibr
collabor
studi
evalu
serum
need
order
satisfi
requir
intern
refer
antiserum
sar
sever
acut
respiratori
infect
diseas
safe
effect
vaccin
would
import
complement
exist
sar
control
strategi
neutral
antibodi
sar
viru
immun
anim
measur
potenti
serolog
assay
wellcharacter
sar
refer
antiserum
great
necess
provid
reliabl
standard
evalu
qualiti
control
assay
moreov
instruct
develop
inactiv
vaccin
sar
viru
current
report
summar
prepar
character
calibr
sar
refer
antiserum
accord
biolog
refer
requir
correspond
author
fax
email
address
zhangj
sinovaccom
j
zhang
viral
strain
sar
viral
strain
isol
pharyng
swab
clinic
confirm
sar
patient
peke
union
hospit
sar
viru
propag
vero
cell
cultur
flask
cultiv
c
cell
show
cytopath
effect
three
freezethaw
cycl
viru
harvest
well
character
batch
viru
store
c
refer
viru
manuscript
prepar
neutral
assay
harvest
sar
viru
inactiv
total
protein
purifi
centrifug
ultrafiltr
gel
filtrat
gel
filtrat
elut
use
western
blot
assay
vero
cell
line
african
green
monkey
kidney
cell
obtain
atcc
american
type
cultur
collect
vero
cell
grown
c
minimum
essenti
medium
mem
contain
wv
fetal
calf
serum
wv
glutamin
panel
posit
sera
collect
patient
convalesc
stage
sar
heat
inactiv
c
min
store
c
order
verifi
inactiv
effici
vero
cell
inocul
inactiv
serum
cultiv
three
gener
cytopath
effect
detect
addit
panel
serum
sampl
collect
healthi
peopl
neg
control
vero
cell
cultiv
plate
c
form
confluent
monolay
cell
inocul
l
per
well
viral
suspens
reconstitut
dilut
serial
tenfold
step
mem
contain
newborn
calf
serum
gml
penicillin
ph
dilut
fill
plate
incub
c
co
incub
viru
titr
express
cell
cultur
infecti
dose
ccid
dilut
viru
caus
half
cultur
cell
produc
cpe
cytopath
effect
heat
inactiv
sera
twofold
serial
dilut
l
dilut
ad
equal
volum
viru
dilut
l
incub
c
ad
confluent
monolay
vero
cell
plate
incub
c
co
incub
day
incub
period
cell
cultur
check
develop
cpe
protein
sdspage
gel
transfer
onto
nitrocellulos
membran
immunostain
transfer
protein
block
membran
incub
convalesc
serum
antihuman
antibodi
conjug
hrp
horseradish
peroxidas
sigma
use
second
antibodi
color
develop
substrat
dab
convalesc
serum
sar
identifi
confirm
commerci
obtain
enzymelink
immunosorb
assay
elisa
kit
beij
wantai
antigen
protein
employ
elisa
kit
part
recombin
n
protein
sar
cov
polypeptid
product
third
orf
n
protein
code
region
express
escherichia
coli
strain
purifi
sar
viru
protein
immobil
plate
antiserum
sar
viru
ad
coat
well
incub
hrplabel
sar
antigen
ad
react
bound
antiserum
tmb
use
color
develop
serum
mix
thoroughli
fill
ampoul
mlampoul
serum
freezedri
ampoul
seal
moistur
content
freezedri
refer
antiserum
detect
karl
fischer
method
describ
previous
moistur
content
least
three
ampoul
test
separ
stabil
refer
antiserum
test
acceler
degrad
test
use
temperatur
c
day
storag
respect
potenc
determin
neutral
assay
sampl
monitor
c
store
sampl
virus
electron
microscop
visual
appear
clearli
corona
viru
typic
characterist
cytopath
chang
could
seen
virus
inocul
vero
cell
suscept
sar
viru
infect
two
viru
strain
use
extens
research
sequenc
similar
avail
sar
cov
viru
sequenc
accept
genbank
access
number
viru
could
neutral
convalesc
sera
evid
prove
viru
use
sar
corona
viru
antiserum
male
sar
patient
clear
epidemiolog
histori
confirm
clinic
male
patient
identifi
sar
probabl
case
accord
criteria
confirm
sar
case
accord
diagnosi
criteria
chines
ministri
health
infect
sar
contact
sar
patient
zhangjiak
hospit
affili
zhangjiak
medic
institut
two
patient
close
contact
also
show
sar
symptom
fever
cough
dyspnea
pulmonari
could
detect
xray
check
also
confirm
sar
probabl
case
accord
criteria
confirm
sar
case
accord
diagnosi
criteria
chines
ministri
health
patient
interview
ascertain
contact
convalesc
serum
collect
patient
name
inactiv
process
antibodi
specif
serum
identifi
elisa
western
blot
assay
neutral
assay
convalesc
sera
collect
sar
patient
probabl
case
accord
criteria
inner
mogolia
autonom
region
neimenggu
thu
three
letter
initi
code
nei
citi
beij
zhang
jiakou
thu
three
letter
initi
code
jing
zhang
respect
collect
arrang
chines
ministri
health
china
cdc
sera
collect
month
post
onset
symptom
nineteen
sera
sera
test
gave
posit
result
neg
one
prove
neg
result
given
tabl
serum
strong
posit
reaction
confirm
sar
antibodi
specif
serum
volum
suffici
refer
prepar
neutral
potenc
close
potenc
gmt
posit
sera
western
blot
assay
perform
identifi
sar
antibodi
serum
band
kda
correspond
sar
n
protein
nucleocapsid
protein
detect
suggest
exist
specif
antisar
antibodi
band
detect
neg
control
serum
result
shown
fig
neutral
assay
demonstr
serum
capabl
neutral
four
sarscov
strain
tabl
identif
design
sar
refer
antiserum
candid
serum
volum
ml
fill
ampoul
freezedri
seal
test
residu
moistur
follow
requir
total
ampoul
obtain
batch
refer
antiserum
assign
lot
number
store
c
charg
special
keeper
neutral
assay
use
calibr
refer
antiserum
repetit
titrat
perform
differ
person
three
differ
time
statist
analysi
identifi
rang
gmt
geometr
mean
titr
antibodi
potenc
result
given
tabl
potenc
sar
refer
antiserum
defin
u
geometr
mean
titr
tabl
neutral
test
result
convalesc
sera
sar
patient
potenc
gmt
sera
neg
serum
moistur
freezedri
sar
refer
antiserum
determin
result
stabil
sar
refer
antiserum
c
given
tabl
experi
stabil
still
progress
result
tabl
show
neutral
antibodi
potenc
decreas
substanti
sar
refer
antiserum
kept
c
day
therefor
storag
condit
sar
refer
antiserum
design
c
dark
time
period
expir
primarili
design
year
world
prepar
face
possibl
resurg
local
sar
epidem
although
progress
made
worldwid
develop
safe
effect
human
vaccin
sar
prevent
still
lack
intern
refer
qualiti
control
express
test
result
recent
sar
laboratori
workshop
agre
urgent
need
qualiti
control
standard
test
protocol
reagent
need
verif
initi
casesclust
nonepidem
period
establish
intern
refer
verif
laboratori
antibodi
capabl
neutral
viru
discov
convalesc
serum
sar
patient
suggest
role
immun
sar
infect
order
fulfil
need
standard
work
potenti
refer
antiserum
effort
search
vaccin
combat
sar
sar
refer
antiserum
serv
refer
differ
serolog
method
immun
anim
success
prepar
test
calibr
qualit
test
includ
elisa
western
blot
assay
neutral
assay
made
clear
refer
antiserum
satisfi
basic
criteria
refer
accord
titrat
result
neutral
antibodi
unit
refer
antiserum
u
primari
result
stabil
show
neutral
antibodi
potenc
refer
antiserum
decreas
substanti
week
stabil
test
still
progress
newli
develop
refer
antiserum
far
inhous
use
accept
becom
intern
refer
candid
done
compli
regul
refer
collabor
titrat
serum
methodolog
verif
